176 related articles for article (PubMed ID: 24246525)
1. Medical contraindications in women seeking combined hormonal contraception.
Xu H; Eisenberg DL; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2014 Mar; 210(3):210.e1-5. PubMed ID: 24246525
[TBL] [Abstract][Full Text] [Related]
2. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with contraceptive use among women living with HIV in Canada: a controlled, cross-sectional study.
Khondoker CC; Kaida A; Marquez A; Campbell AR; Côté HCF; Albert AY; Pick N; Maan EJ; Russell EAB; Prior JC; Elwood C; Brophy J; Murray MCM;
Reprod Health; 2022 Jan; 19(1):3. PubMed ID: 34986848
[TBL] [Abstract][Full Text] [Related]
4. Medical contraindications to estrogen and contraceptive use among women veterans.
Judge CP; Zhao X; Sileanu FE; Mor MK; Borrero S
Am J Obstet Gynecol; 2018 Feb; 218(2):234.e1-234.e9. PubMed ID: 29111146
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
6. Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.
Houvèssou GM; Farías-Antúnez S; da Silveira MF
Sex Reprod Healthc; 2021 Feb; 27():100587. PubMed ID: 33545506
[TBL] [Abstract][Full Text] [Related]
7. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
Mendel A; Bernatsky S; Pineau CA; St-Pierre Y; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae SC; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón G; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
Rheumatology (Oxford); 2019 Jul; 58(7):1259-1267. PubMed ID: 30753683
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
9. Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
Coleman-Minahan K; Ela EJ; White K; Grossman D
Obstet Gynecol; 2021 May; 137(5):907-915. PubMed ID: 33831931
[TBL] [Abstract][Full Text] [Related]
10. Provision of contraception: a survey among primary care physicians in Finland.
Sannisto T; Kosunen E
Acta Obstet Gynecol Scand; 2010 May; 89(5):636-45. PubMed ID: 20423277
[TBL] [Abstract][Full Text] [Related]
11. Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk.
Batur P; Yao M; Bucklan J; Soni P; Suneja A; Farrell R; Mays M
Headache; 2023 Jun; 63(6):813-821. PubMed ID: 36752588
[TBL] [Abstract][Full Text] [Related]
12. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
13. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
14. Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
Rodriguez MI; Kaufman M; Manibusan B; Anderson L; McConnell KJ
Contraception; 2021 Nov; 104(5):547-552. PubMed ID: 34116068
[TBL] [Abstract][Full Text] [Related]
15. [Contraception in Women at Risk].
Birkhäuser M
Ther Umsch; 2022; 79(10):495-512. PubMed ID: 36415940
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
Kurvits K; Laius O; Uusküla M; Laanpere M
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive choices in women with coagulation disorders.
Comp PC; Zacur HA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
[TBL] [Abstract][Full Text] [Related]
18. Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception.
Craig AD; Steinauer J; Kuppermann M; Schmittdiel JA; Dehlendorf C
Contraception; 2019 Feb; 99(2):104-110. PubMed ID: 30227121
[TBL] [Abstract][Full Text] [Related]
19. [The Thromboembolism Risk with Combined Hormonal Contraceptives: Current Status and Prescribing Practice].
Wunder D
Praxis (Bern 1994); 2023; 112(4):199-204. PubMed ID: 36919316
[TBL] [Abstract][Full Text] [Related]
20. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
